Blood Disorder News and Research

RSS
bluebird bio publishes LentiGlobin gene therapy clinical trial data results

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

FDA approves Alexion's Rhode Island manufacturing facility as commercial supply source for Soliris

FDA approves Alexion's Rhode Island manufacturing facility as commercial supply source for Soliris

International conference to discuss research, unresolved issues of sickle cell disease

International conference to discuss research, unresolved issues of sickle cell disease

Long term decline in hemoglobin may announce onset of colorectal cancer

Long term decline in hemoglobin may announce onset of colorectal cancer

Taoist Tai Chi internal arts of health celebrates 40 years

Taoist Tai Chi internal arts of health celebrates 40 years

New drug to treat chronic pain in SCD patients

New drug to treat chronic pain in SCD patients

Alexion second-quarter non-GAAP net income increases 56% to $36.9 million

Alexion second-quarter non-GAAP net income increases 56% to $36.9 million

The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

The Children's Hospital, UCH to jointly establish new center for advanced maternal fetal medicine

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

Gene therapy represents safe alternative to current cures for blood disorder β-thalassemia

Qualaquin for treatment of night time leg cramps leads to serious side effects, FDA warns

Qualaquin for treatment of night time leg cramps leads to serious side effects, FDA warns

Pennsylvania Department of Health announces new study on blood disorder Polycythemia vera

Pennsylvania Department of Health announces new study on blood disorder Polycythemia vera

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device

Masimo granted FDA clearance for Pronto-7 noninvasive hemoglobin spot-check testing device

Masimo announces limited market release of Pronto-7 handheld hemoglobin spot-check testing device

Masimo announces limited market release of Pronto-7 handheld hemoglobin spot-check testing device

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Americans who travel abroad could use extra health coverage

Americans who travel abroad could use extra health coverage

New study reinforces urgent need for life-saving vaccines in Africa

New study reinforces urgent need for life-saving vaccines in Africa

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris